Articles by Csaba P. Kovesdy, MD
ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD eAppendix: ACE Inhibitor or ARB Treatment Among Patients With Diabetes and Chronic Kidney Disease
ByLinda F. Fried, MD, MPH,Natalia Petruski-Ivleva, PhD,Kerstin Folkerts, MSc,Niklas Schmedt, DrPH,Priscilla Velentgas, PhD,Csaba P. Kovesdy, MD Targeted Literature Review of the Burden of Illness in Patients With Chronic Kidney Disease and Type 2 Diabetes
ByLinda F. Fried, MD, MPH,Kerstin Folkerts, MSc,Beata Smela, MSc,Kevin Deon Bowrin, MSc,Paul Mernagh, MCom,Aurelie Millier, PhD,Csaba P. Kovesdy, MD Glomerular Filtration Rate Change and Outcomes in Type 2 Diabetes
ByEleanor O. Caplan, PhD,Richard Sheer, BA,Niklas Schmedt, DrPH,Thomas Evers, PhD,Meghan Cockrell, MPH,Michael Tindal, PharmD, MBA,Margaret K. Pasquale, PhD,Csaba P. Kovesdy, MD